Fezolinetant is an orally-active neurokinin-3 (NK3) receptor antagonist that is in a race to market with another candidate in the class from UK-based women’s health specialist KaNDy Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback